267 related articles for article (PubMed ID: 20498310)
21. The Role of
Jiang S; Zhuang H; Zhu F; Wei X; Zhang J; Sun L; Ji S; Wang H; Wu D; Zhao F; Yan R; Yu Y; Chen Y
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0129521. PubMed ID: 34662187
[TBL] [Abstract][Full Text] [Related]
22. Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus.
Mishra NN; Yang SJ; Sawa A; Rubio A; Nast CC; Yeaman MR; Bayer AS
Antimicrob Agents Chemother; 2009 Jun; 53(6):2312-8. PubMed ID: 19332678
[TBL] [Abstract][Full Text] [Related]
23. Telavancin Is Active against Experimental Aortic Valve Endocarditis Caused by Daptomycin- and Methicillin-Resistant Staphylococcus aureus Strains.
Abdelhady W; Bayer AS; Gonzales R; Li L; Xiong YQ
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872064
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of the two-component system and cell-wall biosynthesis-related genes was associated with the reversion to daptomycin susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus.
Iwata Y; Satou K; Tsuzuku H; Furuichi K; Senda Y; Sakai-Takemori Y; Wada T; Fujita S; Miyake T; Yasuda H; Sakai N; Kitajima S; Toyama T; Shinozaki Y; Sagara A; Miyagawa T; Hara A; Shimizu M; Kamikawa Y; Kaneko S; Wada T
Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1839-1845. PubMed ID: 28477235
[TBL] [Abstract][Full Text] [Related]
25. Single nucleotide polymorphism leads to daptomycin resistance causing amino acid substitution-T345I in MprF of clinically isolated MRSA strains.
Nakamura M; Kawada H; Uchida H; Takagi Y; Obata S; Eda R; Hanaki H; Kitasato H
PLoS One; 2021; 16(1):e0245732. PubMed ID: 33481910
[TBL] [Abstract][Full Text] [Related]
26. Impact of Multiple Single-Nucleotide Polymorphisms Within mprF on Daptomycin Resistance in Staphylococcus aureus.
Yang SJ; Mishra NN; Kang KM; Lee GY; Park JH; Bayer AS
Microb Drug Resist; 2018 Oct; 24(8):1075-1081. PubMed ID: 29381428
[TBL] [Abstract][Full Text] [Related]
27. Correlation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant Staphylococcus aureus.
Mishra NN; Bayer AS
Antimicrob Agents Chemother; 2013 Feb; 57(2):1082-5. PubMed ID: 23254419
[TBL] [Abstract][Full Text] [Related]
28. Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin.
Jenson RE; Baines SL; Howden BP; Mishra NN; Farah S; Lew C; Berti AD; Shukla SK; Bayer AS; Rose WE
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601160
[TBL] [Abstract][Full Text] [Related]
29. Daptomycin resistance in methicillin-resistant Staphylococcus aureus is conferred by IS256 insertion in the promoter of mprF along with mutations in mprF and walK.
Yin Y; Chen H; Li S; Gao H; Sun S; Li H; Wang R; Jin L; Liu Y; Wang H
Int J Antimicrob Agents; 2019 Dec; 54(6):673-680. PubMed ID: 31479743
[TBL] [Abstract][Full Text] [Related]
30. In-Host Evolution of Daptomycin Resistance and Heteroresistance in Methicillin-Resistant Staphylococcus aureus Strains From Three Endocarditis Patients.
Ji S; Jiang S; Wei X; Sun L; Wang H; Zhao F; Chen Y; Yu Y
J Infect Dis; 2020 Mar; 221(Suppl 2):S243-S252. PubMed ID: 32176794
[TBL] [Abstract][Full Text] [Related]
31. In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.
Mishra NN; McKinnell J; Yeaman MR; Rubio A; Nast CC; Chen L; Kreiswirth BN; Bayer AS
Antimicrob Agents Chemother; 2011 Sep; 55(9):4012-8. PubMed ID: 21709105
[TBL] [Abstract][Full Text] [Related]
32. Enhanced expression of dltABCD is associated with the development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus.
Yang SJ; Kreiswirth BN; Sakoulas G; Yeaman MR; Xiong YQ; Sawa A; Bayer AS
J Infect Dis; 2009 Dec; 200(12):1916-20. PubMed ID: 19919306
[TBL] [Abstract][Full Text] [Related]
33. Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient--a review of the literature.
van Hal SJ; Paterson DL; Gosbell IB
Eur J Clin Microbiol Infect Dis; 2011 May; 30(5):603-10. PubMed ID: 21191627
[TBL] [Abstract][Full Text] [Related]
34. Impact of daptomycin resistance on Staphylococcus aureus virulence.
Cameron DR; Mortin LI; Rubio A; Mylonakis E; Moellering RC; Eliopoulos GM; Peleg AY
Virulence; 2015; 6(2):127-31. PubMed ID: 25830650
[TBL] [Abstract][Full Text] [Related]
35. Cell wall thickening is associated with adaptive resistance to amikacin in methicillin-resistant Staphylococcus aureus clinical isolates.
Yuan W; Hu Q; Cheng H; Shang W; Liu N; Hua Z; Zhu J; Hu Z; Yuan J; Zhang X; Li S; Chen Z; Hu X; Fu J; Rao X
J Antimicrob Chemother; 2013 May; 68(5):1089-96. PubMed ID: 23322605
[TBL] [Abstract][Full Text] [Related]
36. β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.
Mehta S; Singh C; Plata KB; Chanda PK; Paul A; Riosa S; Rosato RR; Rosato AE
Antimicrob Agents Chemother; 2012 Dec; 56(12):6192-200. PubMed ID: 22985884
[TBL] [Abstract][Full Text] [Related]
37. Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach.
Fischer A; Yang SJ; Bayer AS; Vaezzadeh AR; Herzig S; Stenz L; Girard M; Sakoulas G; Scherl A; Yeaman MR; Proctor RA; Schrenzel J; François P
J Antimicrob Chemother; 2011 Aug; 66(8):1696-711. PubMed ID: 21622973
[TBL] [Abstract][Full Text] [Related]
38. Novel Daptomycin Tolerance and Resistance Mutations in Methicillin-Resistant Staphylococcus aureus from Adaptive Laboratory Evolution.
Sulaiman JE; Lam H
mSphere; 2021 Oct; 6(5):e0069221. PubMed ID: 34585959
[TBL] [Abstract][Full Text] [Related]
39. MprF-mediated daptomycin resistance.
Ernst CM; Peschel A
Int J Med Microbiol; 2019 Jul; 309(5):359-363. PubMed ID: 31182276
[TBL] [Abstract][Full Text] [Related]
40. Synergy Mechanisms of Daptomycin-Fosfomycin Combinations in Daptomycin-Susceptible and -Resistant Methicillin-Resistant Staphylococcus aureus:
Mishra NN; Lew C; Abdelhady W; Lapitan CK; Proctor RA; Rose WE; Bayer AS
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0164921. PubMed ID: 34694870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
